A comprehensive view of Combination Therapy. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

CARsgen Therapeutics partners with Roche to assess CARsgen's investigational drug AB011 combined with Roche’s atezolizumab, standard-of-care chemotherapy to treat gastric or gastroesophageal junction cancer; Roche to handle operations, clinical trial

US Patent Issued to Eli Lilly and Co. on Jan. 31 for "Combination therapy with Notch and PI3K/mTOR inhibitors for use in treating cancer" (Indiana Inventors)

US Patent Issued to Five Prime Therapeutics, Bristol-Myers Squibb on Jan. 31 for "Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected cancers" (California, Washington Inventors)

INTERNATIONAL PATENT: BIONTECH SE, GENMAB A/S FILES APPLICATION FOR "MULTISPECIFIC BINDING AGENTS AGAINST CD40 AND CD137 IN COMBINATION THERAPY FOR CANCER"

AIM ImmunoTech enters into clinical research agreement with AstraZeneca and Erasmus Medical Center in the Netherlands; study to evaluate AIM’s Ampligen rintatolimod in combination with AstraZeneca’s Imfinzi durvalumab to treat pancreatic cancer

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count